Trilogy of drug repurposing for developing cancer and chemotherapy-induced heart failure co-therapy agent
Chemotherapy-induced complications, particularly lethal cardiovascular diseases, pose significant challenges for cancer survivors. The intertwined adverse effects, brought by cancer and its complication, further complicate anticancer therapy and lead to diminished clinical outcomes. Simple supplemen...
Main Authors: | Xin Chen, Xianggang Mu, Lele Ding, Xi Wang, Fei Mao, Jinlian Wei, Qian Liu, Yixiang Xu, Shuaishuai Ni, Lijun Jia, Jian Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383523004276 |
Similar Items
-
Repurposed Drugs in Gastric Cancer
by: Diana Araújo, et al.
Published: (2022-12-01) -
Enhancing the anticancer immune response with the assistance of drug repurposing and delivery systems
by: Zile Fu, et al.
Published: (2023-07-01) -
Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?
by: Zhe Li, et al.
Published: (2016-10-01) -
Drug Repurposing in Cancer Therapy: Influence of Patient’s Genetic Background in Breast Cancer Treatment
by: Rafaela Rodrigues, et al.
Published: (2022-04-01) -
Drug Repurposing in the Chemotherapy of Infectious Diseases
by: Amal Hamid, et al.
Published: (2024-01-01)